Go Pro
→ How Long Does $2.5M Last in Retirement? (From SmartAsset) (Ad)tc pixel Free SDCCQ Stock Alerts

SmileDirectClub (SDCCQ) Competitors

Compare

SDCCQ vs. SSKN, GMVDF, TTOO, VRAYQ, and AFIB

Should you buy SmileDirectClub stock or one of its competitors? SmileDirectClub's main competitors and comparable companies include Strata Skin Sciences (SSKN), G Medical Innovations (GMVDF), T2 Biosystems (TTOO), ViewRay (VRAYQ), and Acutus Medical (AFIB). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does SmileDirectClub compare to Strata Skin Sciences?

SmileDirectClub (NASDAQ:SDCCQ) and Strata Skin Sciences (NASDAQ:SSKN) are both small-cap healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, media sentiment, risk, analyst recommendations, earnings, dividends and profitability.

Strata Skin Sciences has lower revenue, but higher earnings than SmileDirectClub. Strata Skin Sciences is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A
Strata Skin Sciences$30.98M0.00-$10.09M-$1.41N/A

SmileDirectClub has a net margin of 0.00% compared to Strata Skin Sciences' net margin of -35.64%. SmileDirectClub's return on equity of 0.00% beat Strata Skin Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
Strata Skin Sciences -35.64%-476.73%-33.49%

SmileDirectClub has a beta of 1.31, indicating that its stock price is 31% more volatile than the broader market. Comparatively, Strata Skin Sciences has a beta of 0.04, indicating that its stock price is 96% less volatile than the broader market.

Given SmileDirectClub's higher probable upside, analysts plainly believe SmileDirectClub is more favorable than Strata Skin Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SmileDirectClub
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Strata Skin Sciences
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled Strata Skin Sciences'average media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
Strata Skin Sciences Neutral

0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 32.4% of Strata Skin Sciences shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by company insiders. Comparatively, 40.9% of Strata Skin Sciences shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

SmileDirectClub beats Strata Skin Sciences on 9 of the 12 factors compared between the two stocks.

How does SmileDirectClub compare to G Medical Innovations?

G Medical Innovations (NASDAQ:GMVDF) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, media sentiment, analyst recommendations, risk, dividends and valuation.

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
SmileDirectClub Neutral

G Medical Innovations has a beta of 28.73, meaning that its stock price is 2,773% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market.

G Medical Innovations has higher earnings, but lower revenue than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A

6.0% of G Medical Innovations shares are owned by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are owned by institutional investors. 37.1% of G Medical Innovations shares are owned by company insiders. Comparatively, 64.7% of SmileDirectClub shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
SmileDirectClub N/A N/A N/A

Summary

G Medical Innovations beats SmileDirectClub on 3 of the 5 factors compared between the two stocks.

How does SmileDirectClub compare to T2 Biosystems?

SmileDirectClub (NASDAQ:SDCCQ) and T2 Biosystems (NASDAQ:TTOO) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation and institutional ownership.

SmileDirectClub has a beta of 1.31, indicating that its stock price is 31% more volatile than the broader market. Comparatively, T2 Biosystems has a beta of 7.75, indicating that its stock price is 675% more volatile than the broader market.

SmileDirectClub has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
T2 Biosystems -563.16%N/A -174.06%

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
T2 Biosystems Neutral

T2 Biosystems has lower revenue, but higher earnings than SmileDirectClub. T2 Biosystems is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A
T2 Biosystems$7.68M0.00-$50.08M-$3.89N/A

0.1% of SmileDirectClub shares are held by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are held by institutional investors. 64.7% of SmileDirectClub shares are held by company insiders. Comparatively, 0.0% of T2 Biosystems shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

SmileDirectClub beats T2 Biosystems on 5 of the 9 factors compared between the two stocks.

How does SmileDirectClub compare to ViewRay?

ViewRay (NASDAQ:VRAYQ) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment.

ViewRay has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.31, meaning that its stock price is 31% more volatile than the broader market.

15.5% of ViewRay shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 2.5% of ViewRay shares are held by insiders. Comparatively, 64.7% of SmileDirectClub shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
ViewRayN/A N/A N/A
SmileDirectClub N/A N/A N/A

SmileDirectClub has higher revenue and earnings than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ViewRay$102.21M0.00-$107.33MN/AN/A
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A

In the previous week, ViewRay's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
ViewRay Neutral
SmileDirectClub Neutral

Summary

SmileDirectClub beats ViewRay on 4 of the 6 factors compared between the two stocks.

How does SmileDirectClub compare to Acutus Medical?

SmileDirectClub (NASDAQ:SDCCQ) and Acutus Medical (NASDAQ:AFIB) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

Acutus Medical has lower revenue, but higher earnings than SmileDirectClub. Acutus Medical is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.13N/A
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A

0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 56.9% of Acutus Medical shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by company insiders. Comparatively, 5.2% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

SmileDirectClub has a beta of 1.31, meaning that its share price is 31% more volatile than the broader market. Comparatively, Acutus Medical has a beta of 5.73, meaning that its share price is 473% more volatile than the broader market.

SmileDirectClub has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. SmileDirectClub's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
Acutus Medical -272.74%-311.64%-11.57%

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
Acutus Medical Neutral

Summary

SmileDirectClub beats Acutus Medical on 6 of the 10 factors compared between the two stocks.

Get SmileDirectClub News Delivered to You Automatically

Sign up to receive the latest news and ratings for SDCCQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SDCCQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SDCCQ vs. The Competition

Export
MetricSmileDirectClubHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$40K$5.81B$7.26B$12.73B
Dividend YieldN/A1.76%2.53%8.86%
P/E Ratio0.0025.92273.2925.38
Price / SalesN/A73.28613.4597.56
Price / CashN/A33.1477.8252.26
Price / BookN/A6.0412.896.14
Net Income-$86.40M$150.03M$3.47B$349.01M

SmileDirectClub Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SDCCQ
SmileDirectClub
N/AN/AN/AN/A$40K$470.74MN/A2,700
SSKN
Strata Skin Sciences
N/A$0.01
flat		N/A-99.7%$29K$30.98MN/A120
GMVDF
G Medical Innovations
N/AN/AN/AN/A$26K$4.42MN/A72
TTOO
T2 Biosystems
N/A$0.00
flat		N/A-76.2%$21K$7.68MN/A180
VRAYQ
ViewRay
N/A$0.00
flat		N/AN/A$16K$102.21MN/A300

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SDCCQ) was last updated on 9/4/2026 by MarketBeat.com Staff.
From Our Partners
How Long Does $2.5M Last in Retirement?
Having $2.5 million saved puts you ahead of most Americans, but how long it lasts depends on the decisions you...
SmartAsset | Sponsoredtc pixel
A Simple Guide to Options Trading While It's Still Free
A free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...
True Market Insiders | Sponsoredtc pixel
Before Anthropic becomes impossible to ignore...
Riot Platforms just struck a 20-year, 191-megawatt data-center agreement tied to Anthropic, reportedly worth 9...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Rickards Predicts: Trump to buy tiny $2 stock?
Jim Rickards believes the Trump administration is about to take a direct stake in a $2 stock sitting on the la...
Paradigm Press | Sponsoredtc pixel
Major Buy Alert Issued for September 30th
Keith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...
TradeSmith | Sponsoredtc pixel
A weekly dividend fund holding Nvidia and Palantir
CrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...
Investors Alley | Sponsoredtc pixel
Three companies about to leapfrog Nvidia [And transform the entire industry]
In 1984, a 10000 dollar stake in Apple could have grown to 25 million dollars for early investors who simply g...
Eagle Publishing | Sponsoredtc pixel